Trial Profile
An international, multicenter, randomized, double-masked, placebo-controlled clinical study of the efficacy and safety of Visomitin eye drops in patients with dry eye syndrome (DES).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Plastoquinonyl-decyl-triphenylphosphonium (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 22 Dec 2015 New trial record
- 11 Dec 2015 Results published in the Advances in Therapy